Found 63 matching trials
SGLT2 Inhibitors in Geographic Atrophy PHASE2 AMD is a leading cause of blindness in individuals over 50 years old, with ...
Show More Location
Washington University
Learn More & Join Trial
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care PHASE3 Background Acute Kidney Injury (AKI) is a potentially life-threatening cond...
Show More Learn More & Join Trial
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack. PHASE3 This study will evaluate the effect of dapagliflozin versus placebo, given ...
Show More Learn More & Join Trial
Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes PHASE3 This study is being carried out to see if dapagliflozin in addition to metf...
Show More Learn More & Join Trial
The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes PHASE4 The study is a randomised double blind placebo control cross over trial wit...
Show More Location
CEDAR, Royal Surrey County Hospital
Learn More & Join Trial
SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney Disease PHASE4 This study evaluates the metabolomics changes associated with dapagliflozin...
Show More Location
Virgen de la Victoria University Hospital. Endocrinology Department
Learn More & Join Trial
Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? PHASE4 Left ventricular hypertrophy (LVH) is common in people with type 2 diabetes...
Show More Location
Ninewells Hospital
Learn More & Join Trial
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838) PHASE3 The purpose of the study is to assess the effect of the addition of sitagli...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease PHASE2 The purpose of the study is to evaluate the dose-response efficacy, safety,...
Show More Learn More & Join Trial
DAPAgliflozin for Renal Protection in Heart Transplant Recipients PHASE3 Kidney failure is common in heart transplant recipients and is a major caus...
Show More Status
Active Not Recruiting
Location
University Medical Center Groningen
Learn More & Join Trial